September 2020

Chemotherapy could be damaging children’s heart cells | 5 ways to keep patients safe as the pandemic continues ()
September in Review: The 'ideal' diet for heart health | Hydroxychloroquine and CV outcomes | COVID-19 & hypotension ()
COVID-19 & in-hospital cardiac arrest | New study highlights the benefits of choosing TAVR over surgery ()
It's World Heart Day! | Sending STEMI patients home early after PCI | Diabetes meds that help with heart, kidney disease ()
Electrophysiology & Arrhythmia: Hydroxychloroquine & CV outcomes | Fitbit & AFib detection | Early rhythm control therapy ()
Practice Management: Burnout in cardiology | Lessons learned from the pandemic | Patients crave personalized care ()
CVD is down among the rich, but not everyone | Hydroxychloroquine & QTc prolongation | COVID-19 & thromboembolism ()
Weekend Edition: FDA data on hydroxychloroquine | TAVR & AFib | Skip the aspirin after PCI? | Repeat heart attacks ()
New map of the heart offers ‘a goldmine of information’ | A blood test for stroke? | Doc files lawsuit after being terminated ()
Hydroxychloroquine, chloroquine linked to severe CV side effects | Resuming sexual activity after a heart attack ()
Hypertension: COVID-19 & hypotension | At-home blood pressure monitoring | Telmisartan & abdominal aortic aneurysms ()
TAVR outcomes after 1 year & AFib | A new heart transplant technique | FDA keeps eyes on digital health solutions ()
Repeat heart attacks are down, especially among women | Predicting CIED-related infections ()
New data on stroke patients with COVID-19 | A beloved cardiologist passes away | BAV repair outcomes ()
Magazine article news ()
The 'ideal' diet for heart health | COVID-19 & hypotension | Cardiac imaging for asymptomatic COVID-19 patients ()
Statin use prior to hospital admission benefits COVID-19 patients | Telmisartan & abdominal aortic aneurysms ()
Vascular & Endovascular: Blood thinners & COVID-19 | IVL for calcified lesions | Blood transfusions & stroke outcomes ()
Structural & Congenital Heart Disease: TAVR & CKD | A historic first | Endocarditis after TAVR ()
Heart transplants from obese patients | Out-of-hospital cardiac arrest | Cardiologist apologizes for Black Lives Matter comments ()
Acute Coronary Syndrome: Predicting a CVD patient's cancer risk | ‘Selfies’ that use AI to save lives ()
Specialists warn against cardiac imaging for asymptomatic COVID-19 patients | TAVR & chronic kidney disease ()
The best diet for heart health, straight from the experts | Blood thinners & COVID-19 | Fitbit's AFib app gains FDA clearance ()
Why some COVID-19 patients should stop taking blood pressure medications | CMR imaging & COVID-related heart damage ()
Weekend Edition: Coronary CTA recommendations | Heart damage from COVID-19 improves over time | Statin spending ()
Heart Failure: Older patients & COVID-related heart damage | Hydroxychloroquine & azithromycin | Empagliflozin ()
Why COVID-19 could be a microvascular disease—and what that means for treatment | Stem cells & heart damage ()
Experts recommend coronary CTA for stable CAD—but one team offers a warning | Treating MIS-C | Big news for Medtronic ()
Healthcare Economics & Policy: Salary updates for cardiologists | Cannabis & CV health | A new proposal from CMS ()
Heart damage from COVID-19 may improve over time | Endocarditis after TAVR | A new tool for cardiac care ()
Cardiovascular Imaging: Shear wave elastography | Cardiac imaging & COVID-19 | IVUS-guided PCI ()
CDC shares new data on hydroxychloroquine—and a warning | Stress CMR imaging safe for treating HFrEF ()
Week in Review: Blood clots & COVID-19 | Cardiologist salaries and productivity | ESC Congress 2020 ()
Cardiologist salaries, productivity continue to climb | At-home blood pressure monitoring | MI patients & heart failure ()
Mystery solved? The latest on blood clots & COVID-19 | Blood pressure variability & dementia | ACC.21 rescheduled ()
Lipids & Metabolic: Severe obesity & COVID-19 | The keto diet & intermittent fasting | Detecting diabetes with AI ()
Breaking News: American College of Cardiology pushes back ACC.21 ()
From ESC Congress 2020: Heart meds & COVID-19, blood transfusions for anemic MI patients | Lifelike heart valve models ()